The substantial beat on earnings estimates and the significant year-over-year revenue growth are strong indicators of Spero Therapeutics' financial health and operational success. Historically, such positive earnings reports can lead to an increase in investor confidence and a potential rise in stock price, especially considering the contrast with the previous quarter's performance miss and subsequent share price drop.